| Literature DB >> 25375150 |
Basem Azab1, Marlene Camacho-Rivera2, Emanuela Taioli2.
Abstract
INTRODUCTION: Several studies reported the negative impact of elevated neutrophil/lymphocyte ratio (NLR) on outcomes in many surgical and medical conditions. Previous studies used arbitrary NLR cut-off points according to the average of the populations under study. There is no data on the average NLR in the general population. The aim of this study is to explore the average values of NLR and according to race in adult non-institutional United States individuals by using national data.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25375150 PMCID: PMC4223021 DOI: 10.1371/journal.pone.0112361
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Sample characteristics among NHANES 2007–2010 participants (n = 9427).
| Variable | Categories | Subjectstested (N) | WeightedPrevalence(95% CI) |
|
| Hispanic | 2904 | 14.72 (10.92–18.53) |
| Non-Hispanic White | 4270 | 67.11 (61.77–72.44) | |
| Non-Hispanic Black | 1756 | 11.03 8.92–13.14) | |
| Other Non-Hispanic | 497 | 07.14 (5.46–8.82) | |
|
| Male | 4625 | 49.03 (47.95–50.11) |
| Female | 4802 | 50.97 (49.89–52.04) | |
|
| 9427 | 47.56 (46.92–48.21) | |
|
| < high school | 2842 | 19.96 (18.15–21.77) |
| High school or equiv | 2246 | 24.09 (22.31–25.88) | |
| > high school | 4325 | 55.84 (53.12–58.57) | |
|
| 8548 | 2.97 (2.88–3.07) | |
|
| Insured | 6871 | 78.33 (76.56–80.10) |
|
| Yes | 1044 | 7.64 (6.69–8.60) |
| Borderline | 162 | 1.6 (1.25–1.86) | |
|
| Yes | 517 | 4.06 (3.57–4.55) |
|
| <18.5 | 140 | 1.64 (1.20–2.10) |
| 18.5–24.9 | 2469 | 29.20 (27.60–30.79) | |
| 25.0–29.9 | 3167 | 33.82 (32.37–35.27) | |
| ≥30.0 | 3562 | 35.34 (33.78–36.90) | |
|
| Yes | 4322 | 44.85 (42.37–47.34) |
|
| Yes | 6213 | 76.64 (74.43–78.55) |
|
| |||
|
| 9427 | 4.27 (4.20–4.34) | |
|
| 9427 | 2.14 (2.11–2.16) | |
|
| 9427 | 2.15 (2.11–2.19) |
Neutrophil, Lymphocyte, and NLR according to demographic and clinical characteristics (n = 9427).
| Variable | Categories | NeutrophilMean (95% CI) | LymphocyteMean (95% CI) | NLRMean (95% CI) |
|
| Hispanic | 4.39 (4.31–4.48) | 2.26 (2.23–2.29) | 2.08 (2.04–2.12) |
| Non-Hispanic White | 4.35 (4.27–4.44) | 2.09 (2.06–2.12) | 2.24 (2.19–2.28) | |
| Non-Hispanic Black | 3.65 (3.56–3.73) | 2.24 (2.21–2.28) | 1.76 (1.71–1.81) | |
| Other Non-Hispanic | 4.18 (4.00–4.37) | 2.11 (2.05–2.17) | 2.10 (2.01–2.19) | |
|
| Male | 4.26 (4.18–4.33) | 2.11 (2.08–2.13) | 2.19 (2.14–2.25) |
| Female | 4.28 (4.20–4.36) | 2.16 (2.14–2.19) | 2.11 (2.07–2.16) | |
|
| < high school | 4.44 (4.32–4.56) | 2.22 (2.19–2.26) | 2.16 (2.09–2.24) |
| High school or equiv | 4.45 (4.34–4.56) | 2.19 (2.15–2.23) | 2.20 (2.14–2.26) | |
| > high school | 4.13 (4.07–4.20) | 2.08 (2.06–2.10) | 2.13 (2.08–2.17) | |
|
| Insured | 4.21 (4.14–4.28) | 2.10 (2.08–2.12) | 2.16 (2.11–2.21) |
| Uninsured | 4.48 (4.37–4.60) | 2.26 (2.21–2.30) | 2.12 (2.06–2.18) | |
|
| Yes | 4.66 (4.50–4.83) | 2.21 (2.15–2.27) | 2.34 (2.23–2.45) |
| No | 4.24 (4.17–4.30) | 2.13 (2.11–2.15) | 2.13 (2.09–2.17) | |
| Borderline | 4.27 (3.88–4.67) | 2.06 (1.97–2.15) | 2.21 (2.01–2.41) | |
|
| Yes | 4.26 (4.19–4.33) | 2.14 (2.12–2.16) | 2.44 (2.30–2.58) |
| No | 4.45 (4.28–4.61) | 2.03 (1.93–2.12) | 2.14 (2.10–2.18) | |
|
| <18.5 | 3.99 (3.64–4.34) | 2.10 (1.97–2.23) | 2.06 (1.85–2.27) |
| 18.5–24.9 | 3.97 (3.88–4.07) | 2.01 (1.98–2.05) | 2.11 (2.06–2.17) | |
| 25.0–29.9 | 4.18 (4.08–4.28) | 2.11 (2.08–2.15) | 2.13 (2.07–2.20) | |
| ≥30.0 | 4.62 (4.54–4.71) | 2.26 (2.23–2.29) | 2.21 (2.15–2.27) | |
|
| Yes | 4.55 (4.43–4.66) | 2.21 (2.19–2.24) | 2.22 (2.16–2.28) |
| No | 4.04 (4.00–4.09) | 2.07 (2.04–2.10) | 2.10 (2.05–2.14) | |
|
| Yes | 4.28 (4.21–4.35) | 2.13 (2.10–2.16) | 2.16 (2.11–2.20) |
| No | 4.22 (4.11–4.33) | 2.12 (2.08–2.16) | 2.17 (2.09–2.25) |
*P for trend: 0.002;
p for trend<0.0001.
Adjusted Linear Regression Estimates of the association between demographic and clinical characteristics and Neutrophil and Lymphocyte Values (n = 7736).
| Neutrophil | Lymphocyte | NLR | ||||||||
| Variable | Categories | Coeff | 95% CI | p-value | Coeff | 95% CI | p-value | Coeff | 95% CI | p-value |
|
| Hispanic | −0.14 | (−0.27−−0.01) | 0.03 | 0.09 | (0.05–0.13) | <0.0001 | −0.18 | (−0.26−−0.11) | <0.0001 |
| Non-Hispanic White | REF | REF | REF | |||||||
| Non-Hispanic Black | −0.92 | (−1.03 −−0.81) | <0.0001 | 0.10 | (0.06–0.15) | <0.0001 | −0.55 | (−0.61−−0.49) | <0.0001 | |
| Other Non-Hispanic | −0.02 | (−0.21−0.24) | 0.89 | 0.05 | (−0.04–0.13) | 0.24 | −0.07 | (−0.19−0.05) | 0.24 | |
|
| Female vs Male | 0.16 | (0.06–0.26) | 0.002 | 0.10 | (0.07–0.14) | <0.0001 | −0.06 | (−0.13–0.006) | 0.07 |
|
| Continuous | −0.007 | (−0.009–−0.004) | <0.0001 | −0.006 | (−0.007–−0.005) | <0.0001 | 0.004 | (0.002–0.006) | <0.0001 |
|
| <high school | REF | REF | REF | ||||||
| High school or equiv | 0.10 | (−0.02–0.21) | 0.09 | −0.013 | (−0.06–0.31) | 0.55 | 0.05 | (−0.04–0.14) | 0.29 | |
| >high school | −0.12 | (−0.25–0.004) | 0.06 | −0.06 | (−0.10–−0.03) | 0.002 | −0.01 | (−0.09–0.06) | 0.72 | |
|
| Continuous | −0.05 | (−0.08–−0.02) | 0.003 | −0.01 | (−0.02–0.003) | 0.14 | −0.03 | (−0.05–0.007) | 0.01 |
|
| Uninsured vs Insured | 0.20 | (0.02–0.38) | 0.03 | 0.05 | (−0.07–0.10) | 0.09 | 0.02 | (−0.06–0.10) | 0.61 |
|
| Yes | 0.32 | (0.15–0.48) | <0.0001 | 0.08 | (0.02–0.14) | 0.009 | 0.11 | (−0.004–0.23) | 0.06 |
| No | REF | REF | REF | |||||||
| Borderline | −0.16 | (−0.56–0.23) | 0.40 | −0.12 | (−0.24–−0.11) | 0.03 | −0.006 | (−0.22–0.21) | 0.95 | |
|
| Yes vs No | .06 | (−.13–.24) | 0.55 | −0.09 | (−0.21–0.03) | 0.13 | 0.17 | (0.05–0.30) | 0.008 |
|
| <18.5 | 0.04 | (−0.37–0.45) | 0.85 | 0.04 | (−0.10–0.17) | 0.59 | 0.008 | (−0.22–0.24) | 0.94 |
| 18.5–24.9 | REF | REF | REF | |||||||
| 25.0–29.9 | 0.24 | (0.09–0.38) | 0.003 | 0.12 | (0.07–0.16) | <0.0001 | −0.005 | (−0.10–0.09) | 0.91 | |
| ≥30.0 | 0.71 | (0.57–0.85) | <0.0001 | 0.27 | (0.23–0.31) | <0.0001 | 0.08 | (0.001–0.15) | 0.046 | |
|
| Yes vs No | 0.46 | (0.33–0.60) | <0.0001 | 0.15 | (0.12–0.19) | <0.0001 | 0.09 | (0.02–0.16) | 0.015 |
|
| Yes vs No | −0.02 | (−0.14–0.10) | 0.73 | 0.005 | (−0.04–0.05) | 0.81 | −0.03 | (−0.13–0.07) | 0.55 |
Linear Regression Estimates (β coefficients and 95% CI) of the association between clinical and demographic characteristics and NLR according to racial subgroups.
| Variable | Categories | Blacks(n = 1440) | Whites(n = 3684) | Hispanics(n = 2255) |
|
| Female vs Male | −0.09 (−0.19–0.007) | −0.10 (−0.19– −0.02)∧ | 0.04 (−0.05–0.13) |
|
| Continuous | 0.001 (−0.001–0.005) | 0.005 (0.002–0.007) | 0.002 (−0.0001–0.006) |
|
| <high school | REF | REF | REF |
| High school | 0.08 (−0.05–0.21) | − 0.001 (−0.13–0.13) | 0.10 (−0.03–0.23) | |
| >high school | 0.06 (−.08–0.19) | −0.06 (−0.18–0.05) | 0.02 (−0.04–0.09) | |
|
| Continuous | −0.02 (−0.05–0.02) | −0.03 (−0.06– −0.008) ∧ | −0.03 (−0.06–0.003) |
|
| Uninsured vs Insured | −0.05 (−0.16–0.05) | 0.02 (−0.10–0.13) | −0.02 (−0.13–0.08) |
|
| Yes | 0.16 (−0.04–0.37) | 0.15 (−0.05–0.34) | −0.02 (−0.13–0.09) |
| No | REF | REF | REF | |
| Borderline | 0.33 (−0.01–0.66) | −0.05 (−0.33–0.24) | −0.10 (−0.28–0.09) | |
|
| Yes vs no | 0.11 (−0.11–0.33) | 0.15 (−0.01–0.31) | 0.21 (0.002–0.42) |
|
| <18.5 | 0.12 (−0.50–0.73) | −0.02 (−0.31–0.28) | −0.11 (−0.92–0.69) |
| 18.5–24.9 | REF | REF | REF | |
| 25.0–29.9 | −0.001 (−0.19–0.19) | −0.01 (−0.13–0.11) | −0.01 (−.12–0.11) | |
| ≥30.0 | 0.15 (0.0005–0.29) | 0.05 (−0.06–0.15) | 0.07 (−.05–0.20) | |
|
| Yes vs no | 0.02 (−0.08–0.12) | 0.09 (0.002–0.18) | 0.01 (−0.07–0.10) |
|
| Yes vs no | 0.06 (−0.03–0.15) | −0.06 (−0.20–0.08) | 0.06 (−0.04–0.16) |
*p = 0.04;
p<0.0001;
∧p = 0.01.